Renocrit 4000IU (Recombinant Human Erythropoietin PFS) 4000IU/0.4ml

Renocrit 4000IU is a recombinant human erythropoietin injection used to support red blood cell production. This 4000IU/0.4ml prefilled syringe supports anemia management in chronic conditions. Store between 2-8°C to maintain potency. Consult a healthcare provider for suitability.

Strength

4000IU/0.4ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

ZYDUS HEALTHCARE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Renocrit 4000IU is used to treat anemia caused by chronic kidney disease or chemotherapy. It helps increase red blood cell counts by stimulating the bone marrow. Patients with low hemoglobin levels may benefit from this medication. Always follow a doctor's guidance when using erythropoietin injections.

Side Effects

Renocrit 4000IU works by prompting the body to produce more red blood cells, which can improve energy levels and reduce fatigue. Users may notice gradual improvements in oxygen circulation and overall vitality. Effects vary depending on individual health conditions and treatment plans.

Precautions & Warnings

Keep Renocrit 4000IU refrigerated between 2-8°C and protect it from light. Do not freeze or shake the prefilled syringe vigorously. Inspect the solution for particles or discoloration before use. Discard any unused portion after opening as directed.

Avoid Interactions

Certain medications may affect how Renocrit 4000IU works, including blood pressure drugs and immunosuppressants. Avoid alcohol as it may interfere with treatment efficacy. Inform your healthcare provider about all medications and supplements you are taking before starting erythropoietin therapy.

References

Frequently Asked Questions

Renocrit 4000IU is used to treat anemia by increasing red blood cell production in patients with chronic kidney disease or undergoing chemotherapy.

Store Renocrit 4000IU between 2-8°C in a refrigerator and protect it from light. Do not freeze or shake the prefilled syringe.

Renocrit 4000IU may be available for purchase through licensed online pharmacies with a valid prescription.

Common effects may include headache, joint pain, or mild flu-like symptoms. Report persistent issues to a healthcare provider.

Consult a healthcare provider before using Renocrit 4000IU during pregnancy to assess potential risks and benefits.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.